平均随访十年后翻修反式肩关节置换术的长期结果与假体生存率
单中心回顾性分析纳入2006年6月至2019年8月间101例翻修反式肩关节置换术患者,十年累计无翻修假体生存率为85.0%(95%CI 75.1至91.2),一期与二期翻修及不同初始假体间生存率无显著差异。48例完成临床与影像学评估的患者归一化Constant-Murley评分从术前均值21.4%(SD 14.4%)显著改善至十年随访均值70.3%(SD 28.8%;p<0.001),75%患者报告非常满意或满意,肩胛骨下切迹见于29例(60%)且与临床结果负相关。
要点
- 翻修反式肩关节置换十年累计无翻修假体生存率为85.0%(95%CI 75.1至91.2)。
- 一期与二期翻修及不同初始假体间假体生存率无显著差异。
- 肩胛骨下切迹见于29例(60%),其分级与临床结果负相关(Spearman's Rho 0.36;p=0.024)。
核心结论
- 翻修反式肩关节置换术对多种适应证可获得可接受的长期功能结果和良好的假体生存率。
- 一期与二期翻修具有相当的临床结果和生存率。
- 肩胛骨下切迹与显著较低的临床结果和满意度相关,应通过优化重建将其最小化。
研究设计与样本
- 单中心回顾性分析纳入2006年6月至2019年8月间接受翻修反式肩关节置换术的101例患者。
- 临床结果采用Constant-Murley评分(CMS)、关节活动度(ROM)、简易肩关节测试(SST)、主观肩关节值(SSV)和满意度问卷评估。
- 假体生存率采用Kaplan-Meier分析确定,常规X线片评估松动征象、透亮线和肩胛骨切迹。
- 正态分布数据采用配对t检验比较均值,多因素线性回归模型评估影响患者满意度的因素,显著性设定为p<0.05。
主要发现
- 十年累计无翻修假体生存率为85.0%(95%CI 75.1至91.2)。
- 一期与二期翻修之间、以及初始假体(半肩关节置换、全肩关节置换和反式肩关节置换)之间,假体生存率无显著差异。
- 48例完成临床和影像学评估的患者,归一化CMS从术前均值21.4%(SD 14.4%)显著改善至平均十年随访时70.3%(SD 28.8%;p<0.001)。
- 总体75%的患者报告非常满意或满意;平均SST评分为67%(29%至100%),平均SSV为55%(10%至90%)。
- 肩胛骨下切迹见于29例(60%),切迹分级与临床结果负相关(Spearman's Rho 0.36;p=0.024)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: With the growing number of primary arthroplasties of the shoulder being undertaken, revision arthroplasty becomes an increasing challenge. Most revisions are of reverse shoulder arthroplasties (RSAs); however, there is a paucity of long-term results. METHODS: This monocentre retrospective analysis included 101 patients who underwent revision RSA between June 2006 and August 2019. Clinical outcomes were assessed using the Constant-Murley Score (CMS), range of motion (ROM), Simple Shoulder Test (SST), Subjective Shoulder Value (SSV), and satisfaction questionnaires. Implant survival was determined using Kaplan-Meier analysis. Signs of loosening, radiolucent lines, and scapular notching were assessed on routine radiographs. The mean values for the outcomes were compared using a paired t-test for normally distributed data. A multivariate linear regression model was used to assess factors influencing patient satisfaction. Significance was set at p < 0.05. RESULTS: The cumulative revision-free implant survival rate was 85.0% (95% CI 75.1 to 91.2) at ten years. No significant differences in rates of survival were found between one- and two-stage revisions, nor between initial implants (hemiarthroplasty, total shoulder arthroplasty, and RSA). The 48 patients with complete clinical and radiological evaluation showed significant improvement of the normalized CMS from the mean preoperative values (21.4% (SD 14.4%)) to those at a mean follow-up of ten years (70.3% (SD 28.8%); p < 0.001). Overall, 75% of patients reported being either very satisfied or satisfied. The mean SST score was 67% (29% to 100%) and the mean SSV was 55% (10% to 90%). Inferior scapular notching was found in 29 patients (60%). The grades of notching negatively correlated with clinical outcome (Spearman's Rho 0.36; p = 0.024). CONCLUSION: Revision RSA yields acceptable long-term functional outcomes and good implant survival for a variety of indications. One- and two-stage revisions had comparable clinical results and survival. Scapular notching was associated with significantly lower clinical outcome and satisfaction, and should be minimized by optimizing reconstruction.
引用
- Trefzer R, Leisner M, Weishorn J, et al. Long-term results and implant survival of revision reverse shoulder arthroplasty after a mean follow-up of ten years. Bone Joint J. 2025. PMID: 41173048. doi:10.1302/0301-620X.107B11.BJJ-2025-0436.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。